Institute of Comparative Molecular Endocrinology

Publications

45.
Frijters R, Fleuren W, Toonen EJM, Tuckermann JP, Reichardt HM, Maaden H, Elsas A, Lierop M, Dokter W, Vlieg J, Alkema W. Prednisolone-induced differential gene expression in mouse liver carrying wild type or a dimerization-defective glucocorticoid receptor. BMC genomics. 2010; 11359.      [DOI] 
44.
Frijters R, Fleuren W, Toonen EJM, Tuckermann JP, Reichardt HM, Maaden H, Elsas A, Lierop M, Dokter W, Vlieg J, Alkema W. Prednisolone-induced differential gene expression in mouse liver carrying wild type or a dimerization-defective glucocorticoid receptor. BMC genomics. 2010; 11359.      [DOI] 
43.
Wüst S, Tischner D, John M, Tuckermann JP, Menzfeld C, Hanisch U, Brandt J, Lühder F, Reichardt HM. Therapeutic and adverse effects of a non-steroidal glucocorticoid receptor ligand in a mouse model of multiple sclerosis. PloS one. 2009; 4(12):e8202.      [DOI] 
42.
Wüst S, Tischner D, John M, Tuckermann JP, Menzfeld C, Hanisch U, Brandt J, Lühder F, Reichardt HM. Therapeutic and adverse effects of a non-steroidal glucocorticoid receptor ligand in a mouse model of multiple sclerosis. PloS one. 2009; 4(12):e8202.      [DOI] 
41.
Wüst S, Tischner D, John M, Tuckermann JP, Menzfeld C, Hanisch U, Brandt J, Lühder F, Reichardt HM. Therapeutic and adverse effects of a non-steroidal glucocorticoid receptor ligand in a mouse model of multiple sclerosis. PloS one. 2009; 4(12):e8202.      [DOI] 
40.
Hintzen C, Haan C, Tuckermann JP, Heinrich PC, Hermanns HM. Oncostatin M-induced and constitutive activation of the JAK2/STAT5/CIS pathway suppresses CCL1, but not CCL7 and CCL8, chemokine expression. Journal of immunology (Baltimore, Md. : 1950). 2008; 181(10):7341—7349.      [DOI] 
39.
Hintzen C, Haan C, Tuckermann JP, Heinrich PC, Hermanns HM. Oncostatin M-induced and constitutive activation of the JAK2/STAT5/CIS pathway suppresses CCL1, but not CCL7 and CCL8, chemokine expression. Journal of immunology (Baltimore, Md. : 1950). 2008; 181(10):7341—7349.      [DOI] 
38.
Hintzen C, Haan C, Tuckermann JP, Heinrich PC, Hermanns HM. Oncostatin M-induced and constitutive activation of the JAK2/STAT5/CIS pathway suppresses CCL1, but not CCL7 and CCL8, chemokine expression. Journal of immunology (Baltimore, Md. : 1950). 2008; 181(10):7341—7349.      [DOI] 
37.
Wüst S, Brandt J, Tischner D, Kleiman A, Tuckermann JP, Gold R, Lühder F, Reichardt HM. Peripheral T cells are the therapeutic targets of glucocorticoids in experimental autoimmune encephalomyelitis. Journal of immunology (Baltimore, Md. : 1950). 2008; 180(12):8434—8443.      [DOI] 
36.
Wüst S, Brandt J, Tischner D, Kleiman A, Tuckermann JP, Gold R, Lühder F, Reichardt HM. Peripheral T cells are the therapeutic targets of glucocorticoids in experimental autoimmune encephalomyelitis. Journal of immunology (Baltimore, Md. : 1950). 2008; 180(12):8434—8443.      [DOI] 
35.
Wüst S, Brandt J, Tischner D, Kleiman A, Tuckermann JP, Gold R, Lühder F, Reichardt HM. Peripheral T cells are the therapeutic targets of glucocorticoids in experimental autoimmune encephalomyelitis. Journal of immunology (Baltimore, Md. : 1950). 2008; 180(12):8434—8443.      [DOI] 
34.
Kleiman A, Tuckermann JP. Glucocorticoid receptor action in beneficial and side effects of steroid therapy: lessons from conditional knockout mice. Molecular and cellular endocrinology. 2007; 275(1-2):98—108.      [DOI] 
33.
Kleiman A, Tuckermann JP. Glucocorticoid receptor action in beneficial and side effects of steroid therapy: lessons from conditional knockout mice. Molecular and cellular endocrinology. 2007; 275(1-2):98—108.      [DOI] 
32.
Kleiman A, Tuckermann JP. Glucocorticoid receptor action in beneficial and side effects of steroid therapy: lessons from conditional knockout mice. Molecular and cellular endocrinology. 2007; 275(1-2):98—108.      [DOI] 
31.
Textor B, Licht AH, Tuckermann JP, Jessberger R, Razin E, Angel P, Schorpp-Kistner M, Hartenstein B. JunB is required for IgE-mediated degranulation and cytokine release of mast cells. Journal of immunology (Baltimore, Md. : 1950). 2007; 179(10):6873—6880.      [DOI] 
30.
Textor B, Licht AH, Tuckermann JP, Jessberger R, Razin E, Angel P, Schorpp-Kistner M, Hartenstein B. JunB is required for IgE-mediated degranulation and cytokine release of mast cells. Journal of immunology (Baltimore, Md. : 1950). 2007; 179(10):6873—6880.      [DOI] 
29.
Textor B, Licht AH, Tuckermann JP, Jessberger R, Razin E, Angel P, Schorpp-Kistner M, Hartenstein B. JunB is required for IgE-mediated degranulation and cytokine release of mast cells. Journal of immunology (Baltimore, Md. : 1950). 2007; 179(10):6873—6880.      [DOI] 
28.
Tuckermann JP, Kleiman A, Moriggl R, Spanbroek R, Neumann A, Illing A, Clausen BE, Stride B, Förster I, Habenicht AJR, Reichardt HM, Tronche F, Schmid W, Schütz G. Macrophages and neutrophils are the targets for immune suppression by glucocorticoids in contact allergy. The Journal of clinical investigation. 2007; 117(5):1381—1390.      [DOI] 
27.
Tuckermann JP, Kleiman A, Moriggl R, Spanbroek R, Neumann A, Illing A, Clausen BE, Stride B, Förster I, Habenicht AJR, Reichardt HM, Tronche F, Schmid W, Schütz G. Macrophages and neutrophils are the targets for immune suppression by glucocorticoids in contact allergy. The Journal of clinical investigation. 2007; 117(5):1381—1390.      [DOI] 
26.
Tuckermann JP, Kleiman A, Moriggl R, Spanbroek R, Neumann A, Illing A, Clausen BE, Stride B, Förster I, Habenicht AJR, Reichardt HM, Tronche F, Schmid W, Schütz G. Macrophages and neutrophils are the targets for immune suppression by glucocorticoids in contact allergy. The Journal of clinical investigation. 2007; 117(5):1381—1390.      [DOI] 
25.
Vujic Spasic M, Kiss J, Herrmann T, Kessler R, Stolte J, Galy B, Rathkolb B, Wolf E, Stremmel W, Hentze MW, Muckenthaler MU. Physiologic systemic iron metabolism in mice deficient for duodenal Hfe. Blood. 2007; 109(10):4511—4517.      [DOI] 
24.
Vujic Spasic M, Kiss J, Herrmann T, Kessler R, Stolte J, Galy B, Rathkolb B, Wolf E, Stremmel W, Hentze MW, Muckenthaler MU. Physiologic systemic iron metabolism in mice deficient for duodenal Hfe. Blood. 2007; 109(10):4511—4517.      [DOI] 
23.
Verga Falzacappa MV, Vujic Spasic M, Kessler R, Stolte J, Hentze MW, Muckenthaler MU. STAT3 mediates hepatic hepcidin expression and its inflammatory stimulation. Blood. 2007; 109(1):353—358.      [DOI] 
22.
Verga Falzacappa MV, Vujic Spasic M, Kessler R, Stolte J, Hentze MW, Muckenthaler MU. STAT3 mediates hepatic hepcidin expression and its inflammatory stimulation. Blood. 2007; 109(1):353—358.      [DOI] 
21.
Tuckermann JP, Kleiman A, McPherson KG, Reichardt HM. Molecular mechanisms of glucocorticoids in the control of inflammation and lymphocyte apoptosis. Critical reviews in clinical laboratory sciences. 2005; 42(1):71—104.      [DOI]